International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7874504
Review Article
A Case Series and Review of Severe Leptospirosis
 ,
 ,
 ,
Published
April 28, 2023
Abstract
Background: The purpose of this retrospective case review was to identify the different patterns of clinical presentation of severe leptospirosis, and to find out any correlation between organ specific complications and outcome of the patients. Method: Leptospirosis patients who were admitted to the ICU of General Medicine Department of HIMS, Hassan during July 2021 – September 2021 were included. Organ specific involvement in 6 organs namely heart, lung, kidney, liver, vascular, brain and spinal cord was recorded. One score was given to each organ involvement. Score was recorded on admission and discharge. Outcome of the patients were recorded as either discharged or died. Result: Renal, hepatic, hematological involvement was found in all patients. One out of 13 patients died and 12 patients were discharged without any sequele. All patients except one had 3 organ involvements and one had involvement of 4 organs. All patients who had 3 organs involved were discharged without any sequel after an average admission period of 5 days. Conclusion: Outcome of severe leptospirosis was not determined by the involvement of renal, hepatic and hematological systems. 4 or more organ involvement was associated with increased mortality. Combination of respiratory system involvement with neurological involvement was associated with a bad outcome. Seeking critical care management at 3 organ involvement stage would improve the outcome of the patients.
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
392 Views
379 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved